Identification of axial spondyloarthritis (axSpA) remains challenging, frequently resulting in a
diagnostic delay for patients. Current benchmarks of delay are usually reported as mean …

Introduction Few studies have evaluated the impact of delayed diagnosis of axial
spondyloarthritis (axSpA) on the overall burden of disease. The objective of this review was …

Axial spondyloarthritis (AxSpA) is an inflammatory spondyloarthritis (SpA) that has
significant impact on a patient's life. Symptoms, including fatigue, sleep problems …

Spondylarthritis (SpA) is an umbrella term that encompasses a wide range of
rheumatological disorders. Several studies demonstrated that SpA is associated with …

Introduction Ankylosing spondylitis (AS) is a lifelong condition where spinal inflammation
causes chronic back pain and restriction of spinal function. While proinflammatory cytokines …

Aim of the work The aim of the present study was to evaluate effectiveness of anti-tumor
necrosis factor-α (anti-TNFα) in the treatment of spondyloarthritis (SpA) and to assess their …

Background: Literature is unclear how delays in diagnosing axial spondyloarthritis (axSpA)
impacts patient quality-of-life (QoL). Methods: A retrospective longitudinal study of Canadian …

Background: Axial spondyloarthritis (axSpA) causes inflammation of the pelvis and spine,
resulting in chronic pain, impaired range of movement, fatigue and physical disability …

Objective To cross‐culturally adapt the Hamilton axial spondyloarthritis (axial SpA)
screening questionnaire and develop a Chinese version for use in a multi‐ethnic Asian …

Hintergrund Tumornekrosefaktor-α-Inhibitoren für die Behandlung entzündlich-
rheumatischer Erkrankungen gehören zu den umsatzstärksten Arzneimitteln in der …